These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29048633)

  • 41. PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma.
    Goto H; Kariya R; Kudo E; Katano H; Okada S
    Neoplasia; 2024 Oct; 56():101035. PubMed ID: 39096792
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma.
    Goto H; Kojima Y; Matsuda K; Kariya R; Taura M; Kuwahara K; Nagai H; Katano H; Okada S
    Eur J Cancer; 2014 Jul; 50(10):1836-1846. PubMed ID: 24726056
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway.
    Kariya R; Taura M; Suzu S; Kai H; Katano H; Okada S
    Cancer Lett; 2014 Jan; 342(1):52-9. PubMed ID: 24012878
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.
    Bottero V; Sadagopan S; Johnson KE; Dutta S; Veettil MV; Chandran B
    J Virol; 2013 Nov; 87(21):11806-20. PubMed ID: 23986578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inhibition of primary effusion lymphoma engraftment in SCID mice by morpholino oligomers against early lytic genes of Kaposi's sarcoma-associated herpesvirus.
    Zhang YJ; Patel D; Nan Y; Fan S
    Antivir Ther; 2011; 16(5):657-66. PubMed ID: 21817187
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells.
    Saji C; Higashi C; Niinaka Y; Yamada K; Noguchi K; Fujimuro M
    Biochem Biophys Res Commun; 2011 Dec; 415(4):573-8. PubMed ID: 22074820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of oral administration of fucoidan extracted from Cladosiphon okamuranus on tumor growth and survival time in a tumor-bearing mouse model.
    Azuma K; Ishihara T; Nakamoto H; Amaha T; Osaki T; Tsuka T; Imagawa T; Minami S; Takashima O; Ifuku S; Morimoto M; Saimoto H; Kawamoto H; Okamoto Y
    Mar Drugs; 2012 Oct; 10(10):2337-2348. PubMed ID: 23170088
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fucoidan induces G1 phase arrest and apoptosis through caspases-dependent pathway and ROS induction in human breast cancer MCF-7 cells.
    Banafa AM; Roshan S; Liu YY; Chen HJ; Chen MJ; Yang GX; He GY
    J Huazhong Univ Sci Technolog Med Sci; 2013 Oct; 33(5):717-724. PubMed ID: 24142726
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Arctigenin induces the apoptosis of primary effusion lymphoma cells under conditions of glucose deprivation.
    Baba Y; Shigemi Z; Hara N; Moriguchi M; Ikeda M; Watanabe T; Fujimuro M
    Int J Oncol; 2018 Feb; 52(2):505-517. PubMed ID: 29207179
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nigericin Induces Apoptosis in Primary Effusion Lymphoma Cells by Mitochondrial Membrane Hyperpolarization and β-Catenin Destabilization.
    Umeyama H; Shigemi Z; Baba Y; Hara N; Watanabe T; Fujimuro M
    Anticancer Res; 2023 Jun; 43(6):2455-2465. PubMed ID: 37247906
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Up-regulation of tumor suppressor genes by exogenous dhC16-Cer contributes to its anti-cancer activity in primary effusion lymphoma.
    Cao Y; Qiao J; Lin Z; Zabaleta J; Dai L; Qin Z
    Oncotarget; 2017 Feb; 8(9):15220-15229. PubMed ID: 28146424
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fucoidan inhibits the proliferation of human urinary bladder cancer T24 cells by blocking cell cycle progression and inducing apoptosis.
    Park HY; Kim GY; Moon SK; Kim WJ; Yoo YH; Choi YH
    Molecules; 2014 May; 19(5):5981-98. PubMed ID: 24818577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fucoidan Inhibits the Proliferation of Leiomyoma Cells and Decreases Extracellular Matrix-Associated Protein Expression.
    Chen HY; Huang TC; Lin LC; Shieh TM; Wu CH; Wang KL; Hong YH; Hsia SM
    Cell Physiol Biochem; 2018; 49(5):1970-1986. PubMed ID: 30235439
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma.
    Goto H; Kudo E; Kariya R; Taura M; Katano H; Okada S
    J Cancer Res Clin Oncol; 2015 Mar; 141(3):465-74. PubMed ID: 25304617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2017 Aug; 51(2):633-643. PubMed ID: 28586006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cyclooxygenase-2-prostaglandin E2-eicosanoid receptor inflammatory axis: a key player in Kaposi's sarcoma-associated herpes virus associated malignancies.
    Paul AG; Chandran B; Sharma-Walia N
    Transl Res; 2013 Aug; 162(2):77-92. PubMed ID: 23567332
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncolytic Reactivation of KSHV as a Therapeutic Approach for Primary Effusion Lymphoma.
    Zhou F; Shimoda M; Olney L; Lyu Y; Tran K; Jiang G; Nakano K; Davis RR; Tepper CG; Maverakis E; Campbell M; Li Y; Dandekar S; Izumiya Y
    Mol Cancer Ther; 2017 Nov; 16(11):2627-2638. PubMed ID: 28847988
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Midkine inhibitor (iMDK) induces apoptosis of primary effusion lymphoma via G2/M cell cycle arrest.
    Ueno M; Kariya R; Gunya S; Cheevapruk K; Okada S
    Leuk Res; 2022 May; 116():106826. PubMed ID: 35316715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells.
    Matsumoto S; Nagaoka M; Hara T; Kimura-Takagi I; Mistuyama K; Ueyama S
    Clin Exp Immunol; 2004 Jun; 136(3):432-9. PubMed ID: 15147344
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of Ingesting Fucoidan Derived from
    Tomori M; Nagamine T; Miyamoto T; Iha M
    Mar Drugs; 2021 Jun; 19(6):. PubMed ID: 34203925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.